Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
- GO: Biological process
- GO: Molecular function
- GO: Cellular component
Phenotypes
Genetic Variation
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: MAPK12 ENSBTAG00000019574

.

Description

mitogen-activated protein kinase 12 [Source:VGNC Symbol;Acc:VGNC:31215]

Location

Primary_assembly 5: 119,618,819-119,626,747 reverse strand.

ARS-UCD1.3:CM008172.2

About this gene

This gene has 4 transcripts (splice variants), 287 orthologues and 19 paralogues.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSBTAT00000026080.6	MAPK12-201	1684	367aa	ENSBTAP00000026080.4	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A5PJL3	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1,
ENSBTAT00000120619.1	MAPK12-204	2215	365aa	ENSBTAP00000085692.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	-	-
ENSBTAT00000080534.2	MAPK12-202	1654	357aa	ENSBTAP00000069778.2	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A3Q1MF91	-
ENSBTAT00000078664.2	MAPK12-203	1633	350aa	ENSBTAP00000060218.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A3Q1LKQ5	-

.

Summary

.

.